GlassScriptPhysician profile
Vinay Jagadeesha
NPI 1518175777
$1,895.80
in general payments reported to CMS, 2019-2025
34 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $214 · 2021: $514 · 2022: $370 · 2023: $233 · 2024: $118 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.60 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $406.71 | 2020-2025 | |
| Novo Nordisk INC | $264.85 | 2019-2025 | Rybelsus, Ozempic |
| Sanofi-Aventis U.S. LLC | $160.45 | 2019-2021 | |
| Glaxosmithkline, LLC. | $117.48 | 2019-2025 | Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $101.61 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $99.55 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $86.24 | 2022-2025 | Gvoke Hypopen |
| Pfizer INC. | $61.30 | 2019-2024 | |
| Esperion Therapeutics, INC. | $51.46 | 2021-2025 | Nexletol |
| Exact Sciences Corporation | $40.29 | 2024-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $39.40 | 2019-2024 | Jardiance, Trulicity, Mounjaro |
| Novartis Pharmaceuticals Corporation | $38.82 | 2019-2021 | |
| Abbott Laboratories | $33.76 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $32.59 | 2020-2021 | |
| Amgen INC. | $32.40 | 2019-2023 | Repatha, Otezla |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $27.95 | 2023 | Gemtesa |
| Mylan Specialty L.P. | $25.84 | 2019-2021 | |
| Urovant Sciences INC | $24.30 | 2022 | |
| Axsome Therapeutics, INC. | $20.46 | 2025 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $19.62 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $18.73 | 2023 | Rexulti |
| Boston Scientific Corporation | $18.27 | 2025 | Watchman Flx |
| Collegium Pharmaceutical, INC. | $17.97 | 2021 | |
| Hologic Sales and Service, LLC | $16.73 | 2023 | Aptima, Thinprep 2000 Processor |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.73 | 2019 | |
| Sunovion Pharmaceuticals INC. | $15.16 | 2021 | |
| Virtus Pharmaceuticals LLC | $14.71 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.43 | 2019 | |
| Eisai INC. | $14.37 | 2020 | |
| Sk Life Science, INC. | $13.34 | 2021 | |
| Avanir Pharmaceuticals, INC. | $13.10 | 2019 | |
| Cvrx, INC. | $13.07 | 2025 | Barostim Neo System |
| Forte Bio-Pharma LLC | $13.01 | 2021 | |
| Genentech USA, INC. | $12.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinay Jagadeesha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.